Low bose cytarabine with or without anthracycline in the induction treatment of elderly patients with acute myeloid leukemia / Ahmad Abdel Raheem Ahmad Abdel Raheem ; Supervised Fouad M. Abu-Taleb , Osman M. Mansour , Nahla El Sharkawy

By:

Ahmad Abdelraheem Ahmad Abdelraheem

Contributor(s):

Material type: Text

TextLanguage: English Publication details: Cairo : Ahmad Abdelraheem Ahmad Abdelraheem , 2011Description: 187 P. : charts ; 25cmOther title:

الجرعات المنخفضة من عقار السيتارابين مع أو بدون عقار الانثراسيكلين كعلاج مبدني لكبار السن من مرضى سرطان الدم الميلودى الحاد [Added title page title]

Subject(s):

Available additional physical forms:

Issued also as CD

Dissertation note: Thesis (Ph.D.) - Cairo University - National Cancer Institute - Department of Oncology-Medical Summary: Acute myelogenous leukemia is a disease of the elderly with median age at diagnosis 60 years, despite an improved molecular understanding of AML, treatment has been largely unsuccessful in the population age 60 and older with most patients dying within one year of diagnosis. To compare the outcome of elderly AML patients receiving low dose cytarabine (LDAC) plus doxorubicin versus low dose cytarabine to identify which one is more suitable for elderly AML patient regarding response rate

Tags from this library: No tags from this library for this title. Log in to add tags.

Average rating: 0.0 (0 votes)

Holdings
Item type	Current library	Home library	Call number	Copy number	Status	Date due	Barcode
Thesis	قاعة الرسائل الجامعية - الدور الاول	المكتبة المركزبة الجديدة - جامعة القاهرة	Cai01.19.04.Ph.D.2011.Ah.L (Browse shelf(Opens below))		Not for loan		01010110055192000
CD - Rom	مخـــزن الرســائل الجـــامعية - البدروم	المكتبة المركزبة الجديدة - جامعة القاهرة	Cai01.19.04.Ph.D.2011.Ah.L (Browse shelf(Opens below))	55192.CD	Not for loan		01020110055192000

Browsing المكتبة المركزبة الجديدة - جامعة القاهرة shelves Close shelf browser (Hides shelf browser)

Previous	No cover image available	No cover image available	No cover image available	No cover image available	No cover image available	No cover image available	No cover image available	Next
Previous	Cai01.19.04.Ph.D.2010.Sh.P Phase II study of low dose fixed rate infusion of gemcitabine with cisplatin and dexamethazone in resistant non- hodgkin lymphoma and correlation with MDR and BCL -2 expression /	Cai01.19.04.Ph.D.2010.Sh.P Phase II study of low dose fixed rate infusion of gemcitabine with cisplatin and dexamethazone in resistant non- hodgkin lymphoma and correlation with MDR and BCL -2 expression /	Cai01.19.04.Ph.D.2011.Ah.L Low bose cytarabine with or without anthracycline in the induction treatment of elderly patients with acute myeloid leukemia /	Cai01.19.04.Ph.D.2011.Ah.L Low bose cytarabine with or without anthracycline in the induction treatment of elderly patients with acute myeloid leukemia /	Cai01.19.04.Ph.D.2011.Ah.S Surgical mangement of anterosuperior mediastinal tumors /	Cai01.19.04.Ph.D.2011.Ah.S Surgical mangement of anterosuperior mediastinal tumors /	Cai01.19.04.Ph.D.2011.Ka.L Low dose prolonged infusion gemcitabine and cisplatin versus conventional gemcitabine in patients with advanced bladder cancer : A phase II trial /	Next

Thesis (Ph.D.) - Cairo University - National Cancer Institute - Department of Oncology-Medical

Acute myelogenous leukemia is a disease of the elderly with median age at diagnosis 60 years, despite an improved molecular understanding of AML, treatment has been largely unsuccessful in the population age 60 and older with most patients dying within one year of diagnosis. To compare the outcome of elderly AML patients receiving low dose cytarabine (LDAC) plus doxorubicin versus low dose cytarabine to identify which one is more suitable for elderly AML patient regarding response rate

Issued also as CD

There are no comments on this title.

to post a comment.